Asao T, Watanabe S, Tanaka T, Morita S, et al. A phase II study of carboplatin and etoposide plus durvalumab for previously untreated extensive-stage small-cell lung cancer (ES-SCLC) patients with a poor performance status (PS): NEJ045A study protocol. BMC Cancer 2022;22:1135.
PMID: 36333680